Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.
about
Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.Feasibility study of TSPO quantification with [18F]FEPPA using population-based input functionVoxel-based imaging of translocator protein 18 kDa (TSPO) in high-resolution PET.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.Application of microPET imaging approaches in the study of pediatric anesthetic-induced neuronal toxicity.Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging.Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Microglial activation in Parkinson's disease using [18F]-FEPPA.In vivo PET imaging of neuroinflammation in Alzheimer's disease.Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.Are We Moving Closer to Noninvasive Imaging and Monitoring of Neonatal Anesthesia-induced Neurotoxicity?Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).Sifting through the surfeit of neuroinflammation tracers.Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11C]DPA-713 positron emission tomography.Mitochondrial function in individuals at clinical high risk for psychosis.MicroPET/CT Imaging of [18F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity
P2860
Q33834306-7926EBA0-A82A-4CD6-9F65-F850532A01E4Q34701163-47B47AAE-7641-4CE1-AD6F-D702551D021EQ34778858-CCC70FF7-B33D-422F-AD16-59EED8114B1AQ34789872-85F8E0D5-21C4-4626-ABF0-BA189EA7DC21Q35779298-002674AE-19C8-4F93-B848-83CDA0815232Q36008271-D6A6B83B-A2EB-4952-BEDA-BE4810539262Q36381512-163B5E62-988C-4B71-85F4-22E2C1E471B2Q36655427-3B7974FA-2273-4712-80B3-8F117948FEDCQ37718960-C45858A2-DC98-4849-9593-89B8C7DBFB39Q38080768-FFBDEDD5-F48F-4C73-A79F-E6C061BDF511Q38506602-36B5D3E4-C08B-4D0F-8A49-E98CB213E002Q38730353-B823FF87-99F4-4FAB-8A2F-A838C591FD61Q38770651-52EF6F87-50C6-4102-A644-77064FDF318EQ38779574-CBCD9F69-7339-4919-83AC-0E37A4DE1DFDQ39409090-8ECF0E61-7813-4ACC-BCE1-59CD725596C4Q39415063-3C0E23C6-6EB8-4F53-B956-7DFAC8381686Q39666235-D837D8E2-3E1C-4C4F-BE57-C08D38C40AA6Q40163732-2FEC7D2F-D12B-4865-A7E8-6810693709A7Q40842870-04AE00A1-668B-4475-A9D3-11AEAAC8F431Q40965410-87A85F23-D8C7-45D1-9E46-DA380C299CAAQ41994846-96C49223-B090-4C45-859A-CBEE86A950CCQ44837532-E0529BC2-C79A-4CAB-BCCC-E882F5FC7FF8Q44951340-CEF4E70E-0A65-42E0-851E-700B13F8ABD2Q47277552-6A0D3F83-95B2-45C8-973C-1DD983CD6C94Q47979574-6FC2F78B-1492-492C-A793-6E88B36D5E34Q48314517-CEF17A7E-14ED-4D99-9AF6-A4748862737CQ48635249-52096A36-59F6-407A-8111-25CB61239F39Q52316654-A1006C91-B538-4447-A18F-DD52E71F5F7CQ58690129-79D1E854-7370-473B-A4E6-2D4AB02C2216
P2860
Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Quantitation of translocator p ...... positron emission tomography.
@ast
Quantitation of translocator p ...... positron emission tomography.
@en
type
label
Quantitation of translocator p ...... positron emission tomography.
@ast
Quantitation of translocator p ...... positron emission tomography.
@en
prefLabel
Quantitation of translocator p ...... positron emission tomography.
@ast
Quantitation of translocator p ...... positron emission tomography.
@en
P2093
P2860
P356
P1476
Quantitation of translocator p ...... positron emission tomography.
@en
P2093
Alan A Wilson
Irina Vitcu
Jeffrey H Meyer
Pablo M Rusjan
Peter M Bloomfield
Romina Mizrahi
Sylvain Houle
P2860
P304
P356
10.1038/JCBFM.2011.55
P577
2011-04-27T00:00:00Z